Prestwick Chemical Overview
- Year Founded
-
1999
- Status
-
Acquired/Merged
- Employees
-
26
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Prestwick Chemical General Information
Description
Provider of chemical screening libraries and medicinal chemistry services intended to support early-stage drug discovery in the pharmaceutical industry. The company designs and supplies curated libraries of small molecules, including approved drug fragments and bioactive compounds, along with hit identification and custom synthesis services, thereby enabling researchers to accelerate lead discovery with screening results.
Contact Information
Website
www.prestwickchemical.com(Operating Subsidiary)
Corporate Office
- 220 Boulevard Gonthier d'Andernach
- Parc d'innovation
- 67400 Illkirch
- France
Corporate Office
- 220 Boulevard Gonthier d'Andernach
- Parc d'innovation
- 67400 Illkirch
- France
Prestwick Chemical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Prestwick Chemical Comparisons
Industry
Financing
Details
Prestwick Chemical Competitors (4)
One of Prestwick Chemical’s 4 competitors is Nanosyn, a Private Equity-Backed company based in Santa Clara, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Nanosyn | Private Equity-Backed | Santa Clara, CA | ||||
| Cell Biolabs | Corporation | San Diego, CA | ||||
| Enamine | Corporation | Kyiv, Ukraine | ||||
| Evotec | Formerly PE-Backed | Hamburg, Germany |
Prestwick Chemical Patents
Prestwick Chemical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240368109-A1 | Allosteric modulators of nicotinic acetylcholine receptors | Pending | 21-Sep-2021 | ||
| US-20250002448-A1 | Allosteric modulators of nicotinic acetylcholine receptors | Pending | 21-Sep-2021 | ||
| US-12331022-B2 | Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors | Active | 02-May-2019 | ||
| US-20220119351-A1 | Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors | Active | 02-May-2019 | ||
| US-20170152221-A1 | Alpha-7 nicotinic acetylcholine receptor modulators and uses thereof | Active | 13-Jun-2014 | C07C311/29 |
Prestwick Chemical Signals
Prestwick Chemical Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Prestwick Chemical FAQs
-
When was Prestwick Chemical founded?
Prestwick Chemical was founded in 1999.
-
Where is Prestwick Chemical headquartered?
Prestwick Chemical is headquartered in Illkirch, France.
-
What is the size of Prestwick Chemical?
Prestwick Chemical has 26 total employees.
-
What industry is Prestwick Chemical in?
Prestwick Chemical’s primary industry is Drug Discovery.
-
Is Prestwick Chemical a private or public company?
Prestwick Chemical is a Private company.
-
What is Prestwick Chemical’s current revenue?
The current revenue for Prestwick Chemical is .
-
Who are Prestwick Chemical’s investors?
Neuphoria Therapeutics has invested in Prestwick Chemical.
-
Who are Prestwick Chemical’s competitors?
Nanosyn, Cell Biolabs, Enamine, and Evotec are competitors of Prestwick Chemical.
-
When was Prestwick Chemical acquired?
Prestwick Chemical was acquired on 03-Mar-2020.
-
Who acquired Prestwick Chemical?
Prestwick Chemical was acquired by Kainova Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process